Modern management of chronic granulomatous disease

British Journal of Haematology

Volumn 140, Issue 3, 2008, Pages 255-266

  Seger, Reinhard A ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Antifungal agents; Corticosteroids; Gene therapy; Interferon gamma; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; COTRIMOXAZOLE; GAMMA INTERFERON; HLA ANTIGEN; INFLIXIMAB; ITRACONAZOLE; LINEZOLID; MESALAZINE; METRONIDAZOLE; POSACONAZOLE; PREDNISOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEICOPLANIN; VORICONAZOLE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; CHRONIC GRANULOMATOUS DISEASE; GENE THERAPY; GRANULOMA; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LUNG GRANULOMA; MEDIATOR RELEASE; PATIENT SELECTION; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SURVIVAL;

EID: 38349105032     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06880.x     Document Type: Review

References (93)

1. Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Servida, P., Miniero, R., Roncarolo, M.G. Bordignon, C. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296, 2410 2413.
2. Alberti, D., Borsellino, A., Locatelli, C., Nani, R., Cheli, M., Torre, G., Notarangelo, L. Locatelli, G. (2002) Percutaneous transhepatic alcoholization: a new therapeutic strategy in children with chronic granulomatous disease and liver abscess. Pediatric Infectious Disease Journal, 21, 1081 1083.
3. Aouba, A., Terrier, B., Arlet, J.B., Aaron, L., Suarez, F., Lefrere, F. Hermine, O. (2007) Treatment of profound anemia with erythropoietin and steroids in a patient with X-linked chronic granulomatous disease associated with MacLeod erythrocyte phenotype. American Journal of Hematology, 19, 19.
4. Barese, C.N., Goebel, W.S. Dinauer, M.C. (2004) Gene therapy for chronic granulomatous disease. Expert Opinion on Biological Therapy, 4, 1423 1434.
5. Bemiller, L.S., Roberts, D.H., Starko, K.M. Curnutte, J.T. (1995) Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells, Molecules, and Diseases, 21, 239 247.
6. Bjorgvinsdottir, H., Ding, C., Pech, N., Gifford, M.A., Li, L.L. Dinauer, M.C. (1997) Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood, 89, 41 48.
7. Bolanowski, A., Mannon, R.B., Holland, S.M., Malech, H.L., Aschan, J., Palmblad, J., Hale, D.A. Kirk, A.D. (2006) Successful renal transplantation in patients with chronic granulomatous disease. American Journal of Transplantation, 6, 636 639.
8. Briones, M.A., Josephson, C.D. Hillyer, C.D. (2003) Granulocyte transfusion: revisited. Current Hematology Reports, 2, 522 527.
9. Brzica, Jr., S.M., Pineda, A.A., Taswell, H.F. Rhodes, K.H. (1977) Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction. Mayo Clinic Proceedings, 52, 153 156.
10. Bustamante, J., Aksu, G., Vogt, G., de Beaucoudrey, L., Genel, F., Chapgier, A., Filipe-Santos, O., Feinberg, J., Emile, J.F., Kutukculer, N. Casanova, J.L. (2007) BCG-osis and tuberculosis in a child with chronic granulomatous disease. Journal of Allergy and Clinical Immunology, 120, 32 38.
11. Canton, E., Peman, J., Cabrera, E., Velert, M., Orero, A., Pastor, A. Gobernado, M. (1999) Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms. Chemotherapy, 45, 268 276.
12. Carlone, N.A., Cuffini, A.M., Ferrero, M., Tullio, V. Avetta, G. (1989) Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages. Journal of Antimicrobial Chemotherapy, 23, 849 859.
13. Clark, R.A. Klebanoff, S.J. (1979) Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. Journal of Clinical Investigation, 64, 913 920.
14. Cohen, M.S., Isturiz, R.E., Malech, H.L., Root, R.K., Wilfert, C.M., Gutman, L. Buckley, R.H. (1981) Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. American Journal of Medicine, 71, 59 66.
15. Collman, R.J. Dickerman, J.D. (1990) Corticosteroids in the management of cystitis secondary to chronic granulomatous disease. Pediatrics, 85, 219 221.
16. Condino-Neto, A. Newburger, P.E. (2000) Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood, 95, 3548 3554.
17. Danziger, R.N., Goren, A.T., Becker, J., Greene, J.M. Douglas, S.D. (1993) Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. Journal of Pediatrics, 122, 303 305.
18. Dinauer, M.C., Gifford, M.A., Pech, N., Li, L.L. Emshwiller, P. (2001) Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood, 97, 3738 3745.
19. Dorman, S.E., Guide, S.V., Conville, P.S., DeCarlo, E.S., Malech, H.L., Gallin, J.I., Witebsky, F.G. Holland, S.M. (2002) Nocardia infection in chronic granulomatous disease. Clinical Infectious Diseases, 35, 390 394.
20. Duke, K. (2006) Belgian loophole allows Swiss parents a 'saviour' baby. Lancet, 368, 355 356.
21. Eckert, J.W., Abramson, S.L., Starke, J. Brandt, M.L. (1995) The surgical implications of chronic granulomatous disease. American Journal of Surgery, 169, 320 323.
22. European Society of Gene Therapy (2006) One of three successfully treated CGD patients in a Swiss-German gene therapy trial died due to his underlying disease: a position statement from the (ESGT). The Journal of Gene Medicine, 8, 1435.
23. Ezekowitz, R.A., Dinauer, M.C., Jaffe, H.S., Orkin, S.H. Newburger, P.E. (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. New England Journal of Medicine, 319, 146 151.
24. Ezekowitz, R.A., Sieff, C.A., Dinauer, M.C., Nathan, D.G., Orkin, S.H. Newburger, P.E. (1990) Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood, 76, 2443 2448.
25. Fuchs, T.A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V. Zychlinsky, A. (2007) Novel cell death program leads to neutrophil extracellular traps. Journal of Cell Biology, 176, 231 241.
26. Gallin, J.I., Alling, D.W., Malech, H.L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E.M., Turner, M.L., DeCarlo, E.S., Starling, J.M. Holland, S.M. (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. New England Journal of Medicine, 348, 2416 2422.
27. Garcia-Eulate, R., Hussain, N., Heller, T., Kleiner, D., Malech, H., Holland, S. Choyke, P.L. (2006) CT and MRI of hepatic abscess in patients with chronic granulomatous disease. American Journal of Roentgenology, 187, 482 490.
28. Gmunder, F.K. Seger, R.A. (1981) Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim. Pediatric Research, 15, 1533 1537.
29. Goldblatt, D. (2002) Current treatment options for chronic granulomatous disease. Expert Opinion on Pharmacotherapy, 3, 857 863.
30. Greenberg, D.E., Ding, L., Zelazny, A.M., Stock, F., Wong, A., Anderson, V.L., Miller, G., Kleiner, D.E., Tenorio, A.R., Brinster, L., Dorward, D.W., Murray, P.R. Holland, S.M. (2006) A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathogens, 2, e28.
31. Gungor, T., Engel-Bicik, I., Eich, G., Willi, U.V., Nadal, D., Hossle, J.P., Seger, R.A. Steinert, H.C. (2001) Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D- glucose in children with chronic granulomatous disease. Archives of Disease in Childhood, 85, 341 345.
32. Gungor, T., Halter, J., Klink, A., Junge, S., Stumpe, K.D., Seger, R. Schanz, U. (2005) Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation, 79, 1596 1606.
33. Haemmerich, D. Wood, B.J. (2006) Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue. International Journal of Hyperthermia, 22, 563 574.
34. Hamasaki, T., Sakano, T., Kobayashi, M., Sakura, N., Ueda, K. Usui, T. (1989) Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism. European Journal of Clinical Investigation, 19, 404 411.
35. Herbrecht, R., Denning, D.W., Patterson, T.F., Bennett, J.E., Greene, R.E., Oestmann, J.W., Kern, W.V., Marr, K.A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R.H., Wingard, J.R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P.H., Hodges, M.R., Schlamm, H.T., Troke, P.F. de Pauw, B. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine, 347, 408 415.
36. Horwitz, M.E., Barrett, A.J., Brown, M.R., Carter, C.S., Childs, R., Gallin, J.I., Holland, S.M., Linton, G.F., Miller, J.A., Leitman, S.F., Read, E.J. Malech, H.L. (2001) Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. New England Journal of Medicine, 344, 881 888.
37. Ishibashi, F., Mizukami, T., Kanegasaki, S., Motoda, L., Kakinuma, R., Endo, F. Nunoi, H. (2001) Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood, 98, 436 441.
38. Jackson, S.H., Gallin, J.I. Holland, S.M. (1995) The p47phox mouse knock-out model of chronic granulomatous disease. Journal of Experimental Medicine, 182, 751 758.
39. Johnson, L.B. Kauffman, C.A. (2003) Voriconazole: a new triazole antifungal agent. Clinical Infectious Diseases, 36, 630 637.
40. Kikuta, A., Ito, M., Mochizuki, K., Akaihata, M., Nemoto, K., Sano, H. Ohto, H. (2006) Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction. Bone Marrow Transplantation, 38, 665 669.
41. Korman, S.H., Lebensart, P. Shvil, Y. (1990) Hydronephrosis caused by ureteric obstruction in chronic granulomatous disease: successful treatment by percutaneous nephrostomy and antibiotic therapy. Journal of Pediatrics, 116, 740 742.
42. Leavey, P.J., Thurman, G. Ambruso, D.R. (2000) Functional characteristics of neutrophils collected and stored after administration of G-CSF. Transfusion, 40, 414 419.
43. Lekstrom-Himes, J.A., Holland, S.M., DeCarlo, E.S., Miller, J., Leitman, S.F., Chang, R., Baker, A.R. Gallin, J.I. (1994) Treatment with intralesional granulocyte instillations and interferon-gamma for a patient with chronic granulomatous disease and multiple hepatic abscesses. Clinical Infectious Diseases, 19, 770 773.
44. Lublin, M., Bartlett, D.L., Danforth, D.N., Kauffman, H., Gallin, J.I., Malech, H.L., Shawker, T., Choyke, P., Kleiner, D.E., Schwartzentruber, D.J., Chang, R., DeCarlo, E.S. Holland, S.M. (2002) Hepatic abscess in patients with chronic granulomatous disease. Annals of Surgery, 235, 383 391.
45. Malech, H.L., Maples, P.B., Whiting-Theobald, N., Linton, G.F., Sekhsaria, S., Vowells, S.J., Li, F., Miller, J.A., DeCarlo, E., Holland, S.M., Leitman, S.F., Carter, C.S., Butz, R.E., Read, E.J., Fleisher, T.A., Schneiderman, R.D., Van Epps, D.E., Spratt, S.K., Maack, C.A., Rokovich, J.A., Cohen, L.K. Gallin, J.I. (1997) Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proceedings of the National Academy of Sciences of the United States of America, 94, 12133 12138.
46. Malech, H.L., Choi, U. Brenner, S. (2004) Progress toward effective gene therapy for chronic granulomatous disease. Japanese Journal of Infectious Diseases, 57, S27 S28.
47. Marciano, B.E., Rosenzweig, S.D., Kleiner, D.E., Anderson, V.L., Darnell, D.N., Anaya-O'Brien, S., Hilligoss, D.M., Malech, H.L., Gallin, J.I. Holland, S.M. (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics, 114, 462 468.
48. Margolis, D.M., Melnick, D.A., Alling, D.W. Gallin, J.I. (1990) Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. Journal of Infectious Diseases, 162, 723 726.
49. Miki, M., Kajiume, T., Nakamura, K., Kawaguchi, H., Sato, T., Kurita, E., Onodera, R., Hiraoka, A., Mizukami, T., Nunoi, H. Kobayashi, M. (2006) Successful bone marrow transplantation with an intensively immunosuppressive conditioning with low toxicity for high-risk chronic granulomatous disease patients. ASH Annual Meeting Abstracts. Blood, 108, 5354.
50. Mills, E.L., Rholl, K.S. Quie, P.G. (1980) X-linked inheritance in females with chronic granulomatous disease. Journal of Clinical Investigation, 66, 332 340.
51. Modlich, U., Bohne, J., Schmidt, M., von Kalle, C., Knoss, S., Schambach, A. Baum, C. (2006) Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood, 108, 2545 2553.
52. Morgenstern, D.E., Gifford, M.A., Li, L.L., Doerschuk, C.M. Dinauer, M.C. (1997) Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. Journal of Experimental Medicine, 185, 207 218.
53. Mouy, R., Fischer, A., Vilmer, E., Seger, R. Griscelli, C. (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. Journal of Pediatrics, 114, 555 560.
54. Mouy, R., Veber, F., Blanche, S., Donadieu, J., Brauner, R., Levron, J.C., Griscelli, C. Fischer, A. (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. Journal of Pediatrics, 125, 998 1003.
55. Movahedi, M., Aghamohammadi, A., Rezaei, N., Shahnavaz, N., Jandaghi, A.B., Farhoudi, A., Pourpak, Z., Moin, M., Gharagozlou, M. Mansouri, D. (2004) Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. International Archives of Allergy and Immunology, 134, 253 259.
56. Moylett, E.H., Pacheco, S.E., Brown-Elliott, B.A., Perry, T.R., Buescher, E.S., Birmingham, M.C., Schentag, J.J., Gimbel, J.F., Apodaca, A., Schwartz, M.A., Rakita, R.M. Wallace, Jr., R.J. (2003) Clinical experience with linezolid for the treatment of nocardia infection. Clinical Infectious Diseases, 36, 313 318.
57. Muhlebach, T.J., Gabay, J., Nathan, C.F., Erny, C., Dopfer, G., Schroten, H., Wahn, V. Seger, R.A. (1992) Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins. Clinical and Experimental Immunology, 88, 203 206.
58. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N.A., Copeland, N.G., Luthi, U., Hassan, M., Thrasher, A.J., Hoelzer, D., von Kalle, C., Seger, R. Grez, M. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Medicine, 12, 401 409.
59. Ozsahin, H., von Planta, M., Muller, I., Steinert, H.C., Nadal, D., Lauener, R., Tuchschmid, P., Willi, U.V., Ozsahin, M., Crompton, N.E. Seger, R.A. (1998) Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood, 92, 2719 2724.
60. Peman, J., Canton, E., Hernandez, M.T. Gobernado, M. (1994) Intraphagocytic killing of gram-positive bacteria by ciprofloxacin. Journal of Antimicrobial Chemotherapy, 34, 965 974.
61. Perfect, J.R., Savani, D.V. Durack, D.T. (1993) Uptake of itraconazole by alveolar macrophages. Antimicrobial Agents and Chemotherapy, 37, 903 904.
62. von Planta, M., Ozsahin, H., Schroten, H., Stauffer, U.G. Seger, R.A. (1997) Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. European Journal of Pediatric Surgery, 7, 234 236.
63. Pogrebniak, H.W., Gallin, J.I., Malech, H.L., Baker, A.R., Moskaluk, C.A., Travis, W.D. Pass, H.I. (1993) Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Annals of Thoracic Surgery, 55, 844 849.
64. Pollock, J.D., Williams, D.A., Gifford, M.A., Li, L.L., Du, X., Fisherman, J., Orkin, S.H., Doerschuk, C.M. Dinauer, M.C. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genetics, 9, 202 209.
65. Rada, B.K., Geiszt, M., Kaldi, K., Timar, C. Ligeti, E. (2004) Dual role of phagocytic NADPH oxidase in bacterial killing. Blood, 104, 2947 2953.
66. Rappa, G., Anzanello, F., Alexeyev, M., Fodstad, O. Lorico, A. (2007) Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease. European Journal of Haematology, 78, 440 448.
67. Reeves, E.P., Lu, H., Jacobs, H.L., Messina, C.G., Bolsover, S., Gabella, G., Potma, E.O., Warley, A., Roes, J. Segal, A.W. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature, 416, 291 297.
68. de Repentigny, L., Ratelle, J., Leclerc, J.M., Cornu, G., Sokal, E.M., Jacqmin, P. De Beule, K. (1998) Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children. Antimicrobial Agents and Chemotherapy, 42, 404 408.
69. Rex, J.H., Bennett, J.E., Gallin, J.I., Malech, H.L. Melnick, D.A. (1990) Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. Journal of Infectious Diseases, 162, 523 528.
70. + cells from patients with X-linked chronic granulomatous disease. Blood, 100, 4381 4390.
71. Roesler, J., Koch, A., Porksen, G., von Bernuth, H., Brenner, S., Hahn, G., Fischer, R., Lorenz, N., Gahr, M. Rosen-Wolff, A. (2005) Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD). Journal of Evaluation in Clinical Practice, 11, 513 521.
72. Roos, D., van Bruggen, R. Meischl, C. (2003) Oxidative killing of microbes by neutrophils. Microbes and Infection, 5, 1307 1315.
73. Sandborn, W.J. (2003) Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease. Current Gastroenterology Reports, 5, 501 505.
74. Segal, B.H., DeCarlo, E.S., Kwon-Chung, K.J., Malech, H.L., Gallin, J.I. Holland, S.M. (1998) Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore), 77, 345 354.
75. Segal, B.H., Leto, T.L., Gallin, J.I., Malech, H.L. Holland, S.M. (2000) Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore), 79, 170 200.
76. Segal, B.H., Barnhart, L.A., Anderson, V.L., Walsh, T.J., Malech, H.L. Holland, S.M. (2005) Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clinical Infectious Diseases, 40, 1684 1688.
77. Seger, R.A., Gungor, T., Belohradsky, B.H., Blanche, S., Bordigoni, P., Di Bartolomeo, P., Flood, T., Landais, P., Muller, S., Ozsahin, H., Passwell, J.H., Porta, F., Slavin, S., Wulffraat, N., Zintl, F., Nagler, A., Cant, A. Fischer, A. (2002) Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a Survey of the European Experience, 1985-2000. Blood, 100, 4344 4350.
78. Siddiqui, S., Anderson, V.L., Hilligoss, D.M., Abinum, M., Kuijpers, T.W., Masur, H., Witebsky, F.G., Shea, Y.R., Gallin, J.I., Malech, H. Holland, S.M. (2007) Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clinical Infectious Diseases, 45, 673 681.
79. Speert, D.P., Bond, M., Woodman, R.C. Curnutte, J.T. (1994) Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. Journal of Infectious Diseases, 170, 1524 1531.
80. Stein, S., Siler, U., Ott, M.G., Seger, R. Grez, M. (2006) Gene therapy for chronic granulomatous disease. Current Opinion in Molecular Therapeutics, 8, 415 422.
81. Stroncek, D.F., Leonard, K., Eiber, G., Malech, H.L., Gallin, J.I. Leitman, S.F. (1996) Alloimmunization after granulocyte transfusions. Transfusion, 36, 1009 1015.
82. Suzuki, N., Hatakeyama, N., Yamamoto, M., Mizue, N., Kuroiwa, Y., Yoda, M., Takahashi, J., Tani, Y. Tsutsumi, H. (2007) Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. International Journal of Hematology, 85, 70 72.
83. The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. New England Journal of Medicine, 324, 509 516.
84. Van de Velde, H., Georgiou, I., De Rycke, M., Schots, R., Sermon, K., Lissens, W., Devroey, P., Van Steirteghem, A. Liebaers, I. (2004) Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Human Reproduction, 19, 700 708.
85. Vowells, S.J., Fleisher, T.A., Sekhsaria, S., Alling, D.W., Maguire, T.E. Malech, H.L. (1996) Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. Journal of Pediatrics, 128, 104 107.
86. van der Waaij, D., Berghuis, J.M. Lekkerkerk, J.E. (1972) Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. The Journal of Hygiene (London), 70, 605 610.
87. Walsh, T.J., Lutsar, I., Driscoll, T., Dupont, B., Roden, M., Ghahramani, P., Hodges, M., Groll, A.H. Perfect, J.R. (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatric Infectious Disease Journal, 21, 240 248.
88. Weening, R.S., Kabel, P., Pijman, P. Roos, D. (1983) Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. Journal of Pediatrics, 103, 127 130.
89. Weening, R.S., Leitz, G.J. Seger, R.A. (1995) Recombinant human interferon-gamma in patients with chronic granulomatous disease - European follow-up study. European Journal of Pediatrics, 154, 295 298.
90. Winkelstein, J.A., Marino, M.C., Johnston, Jr., R.B., Boyle, J., Curnutte, J., Gallin, J.I., Malech, H.L., Holland, S.M., Ochs, H., Quie, P., Buckley, R.H., Foster, C.B., Chanock, S.J. Dickler, H. (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore), 79, 155 169.
91. Woodman, R.C., Erickson, R.W., Rae, J., Jaffe, H.S. Curnutte, J.T. (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood, 79, 1558 1562.
92. Yang, S., Panoskaltsis-Mortari, A., Shukla, M., Blazar, B.R. Haddad, I.Y. (2002) Exuberant inflammation in nicotinamide adenine dinucleotide phosphate-oxidase-deficient mice after allogeneic marrow transplantation. Journal of Immunology, 168, 5840 5847.
93. Zanditenas, D., Hagege, H., Rosa, I., Cattan, P., Ratel-Saby, S., Lons, T. Chousterman, M. (2004) Inflammatory colitis and chronic granulomatous disease, a steroid-dependent case report. Gastroenterologie Clinique et Biologique, 28, 398 401.